Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2015

01.03.2015 | Original Research

Overuse of Colonoscopy for Colorectal Cancer Screening and Surveillance

verfasst von: Gina R. Kruse, MD, MS, MPH, Sami M. Khan, BA, Alan M. Zaslavsky, PhD, John Z. Ayanian, MD, MPP, Thomas D. Sequist, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Ongoing efforts to increase colorectal cancer (CRC) screening rates have raised concerns that these exams may be overused, thereby subjecting patients to unnecessary risks and wasting healthcare resources.

OBJECTIVE

Our aim was to measure overuse of screening and surveillance colonoscopies among average-risk adults, and to identify correlates of overuse.

DESIGN, SETTING, AND PARTICIPANTS

Our approach was a retrospective cohort study using electronic health record data for patients 50–65 years old with no personal history of CRC or colorectal adenomas with an incident CRC screening colonoscopy from 2001 to 2010 within a multispecialty physician group practice.

MAIN OUTCOME MEASURES

We measured time to next screening or surveillance colonoscopy and predictors of overuse (exam performed more than one year earlier than guideline recommended intervals) of colonoscopies.

KEY RESULTS

We identified 1,429 adults who had an incident colonoscopy between 2001 and 2010, and they underwent an additional 871 screening or surveillance colonoscopies during a median follow-up of 6 years. Most follow-up screening colonoscopies (88 %) and many surveillance colonoscopies (49 %) repeated during the study represented overuse. Time to next colonoscopy after incident screening varied by exam findings (no polyp: median 6.9 years, interquartile range [IQR]: 5.1–10.0; hyperplastic polyp: 5.7 years, IQR: 4.9–9.7; low-risk adenoma: 5.1 years, IQR: 3.3–6.3; high-risk adenoma: 2.9 years, IQR: 2.0–3.4, p < 0.001). In logistic regression models of colonoscopy overuse, an endoscopist recommendation for early follow-up was strongly associated with overuse of screening colonoscopy (OR 6.27, 95 % CI: 3.15–12.50) and surveillance colonoscopy (OR 13.47, 95 % CI 6.61-27.46). In a multilevel logistic regression model, variation in the overuse of screening colonoscopy was significantly associated with the endoscopist performing the previous exam.

CONCLUSIONS

Overuse of screening and surveillance exams are common and should be monitored by healthcare systems. Variations in endoscopist recommendations represent targets for interventions to reduce overuse.
Literatur
1.
Zurück zum Zitat Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.CrossRefPubMedCentralPubMed Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.CrossRefPubMedCentralPubMed
2.
Zurück zum Zitat Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–1595.CrossRefPubMed Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–1595.CrossRefPubMed
3.
Zurück zum Zitat Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.CrossRefPubMed Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.CrossRefPubMed
4.
Zurück zum Zitat Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124(2):544–560.CrossRefPubMed Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124(2):544–560.CrossRefPubMed
5.
Zurück zum Zitat Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130(6):1872–1885.CrossRefPubMed Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130(6):1872–1885.CrossRefPubMed
6.
Zurück zum Zitat Preventive Services US. Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137(2):129–131.CrossRef Preventive Services US. Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137(2):129–131.CrossRef
7.
Zurück zum Zitat Preventive Services US. Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637.CrossRef Preventive Services US. Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637.CrossRef
8.
Zurück zum Zitat Centers for Disease Control and Prevention. Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010. Morb Mortal Wkly Rep. 2011; 60(26):884-889. Centers for Disease Control and Prevention. Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010. Morb Mortal Wkly Rep. 2011; 60(26):884-889.
10.
Zurück zum Zitat Menees SB, Elliott E, Govani S, Anastassiades C, Schoenfeld P. Adherence to recommended intervals for surveillance colonoscopy in average-risk patients with 1 to 2 small (<1 cm) polyps on screening colonoscopy. Gastrointest Endosc. 2014;79(4):551–557.CrossRefPubMedCentralPubMed Menees SB, Elliott E, Govani S, Anastassiades C, Schoenfeld P. Adherence to recommended intervals for surveillance colonoscopy in average-risk patients with 1 to 2 small (<1 cm) polyps on screening colonoscopy. Gastrointest Endosc. 2014;79(4):551–557.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Cooper GS, Kou TD, Barnholtz Sloan JS, Koroukian SM, Schluchter MD. Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer. 2013;119(10):1800–1807.CrossRefPubMedCentralPubMed Cooper GS, Kou TD, Barnholtz Sloan JS, Koroukian SM, Schluchter MD. Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer. 2013;119(10):1800–1807.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Saini SD, Vijan S, Schoenfeld P, Powell AA, Moser S, Kerr EA. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014;348:g1247.CrossRefPubMedCentralPubMed Saini SD, Vijan S, Schoenfeld P, Powell AA, Moser S, Kerr EA. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014;348:g1247.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171(15):1335–1343.CrossRefPubMed Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171(15):1335–1343.CrossRefPubMed
14.
15.
Zurück zum Zitat Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141(4):264–271.CrossRefPubMed Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141(4):264–271.CrossRefPubMed
16.
Zurück zum Zitat Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper GS. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145(9):654–659.CrossRefPubMed Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper GS. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145(9):654–659.CrossRefPubMed
17.
Zurück zum Zitat Krist AH, Jones RM, Woolf SH, et al. Timing of repeat colonoscopy: disparity between guidelines and endoscopists' recommendation. Am J Prev Med. 2007;33(6):471–478.CrossRefPubMed Krist AH, Jones RM, Woolf SH, et al. Timing of repeat colonoscopy: disparity between guidelines and endoscopists' recommendation. Am J Prev Med. 2007;33(6):471–478.CrossRefPubMed
18.
Zurück zum Zitat Robertson RH, Burkhardt JH, Powell MP, Eloubeidi MA, Pisu M, Weissman NW. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. Prev Med. 2006;42(6):460–462.CrossRefPubMed Robertson RH, Burkhardt JH, Powell MP, Eloubeidi MA, Pisu M, Weissman NW. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. Prev Med. 2006;42(6):460–462.CrossRefPubMed
19.
Zurück zum Zitat Laiyemo AO, Doubeni C, Sanderson AK, et al. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc. 2011;74(2):253–261.CrossRefPubMedCentralPubMed Laiyemo AO, Doubeni C, Sanderson AK, et al. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc. 2011;74(2):253–261.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–676.CrossRefPubMed Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–676.CrossRefPubMed
22.
Zurück zum Zitat Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2009;169(4):364–371.CrossRefPubMedCentralPubMed Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2009;169(4):364–371.CrossRefPubMedCentralPubMed
23.
24.
Zurück zum Zitat Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101(4):873–885.CrossRefPubMed Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101(4):873–885.CrossRefPubMed
25.
Zurück zum Zitat Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3):844–857.CrossRefPubMed Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3):844–857.CrossRefPubMed
26.
Zurück zum Zitat Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007;10(3):174–180.CrossRefPubMed Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007;10(3):174–180.CrossRefPubMed
27.
Zurück zum Zitat Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. London: Sage; 1999. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. London: Sage; 1999.
28.
Zurück zum Zitat Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med. 2013;173(7):542–550.CrossRefPubMed Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med. 2013;173(7):542–550.CrossRefPubMed
29.
Zurück zum Zitat Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med. 2003;36(3):352–362.CrossRefPubMed Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med. 2003;36(3):352–362.CrossRefPubMed
30.
Zurück zum Zitat Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26(2):177–184.CrossRefPubMedCentralPubMed Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26(2):177–184.CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Saini SD, Nayak RS, Kuhn L, Schoenfeld P. Why don't gastroenterologists follow colon polyp surveillance guidelines?: results of a national survey. J Clin Gastroenterol. 2009;43(6):554–558.CrossRefPubMed Saini SD, Nayak RS, Kuhn L, Schoenfeld P. Why don't gastroenterologists follow colon polyp surveillance guidelines?: results of a national survey. J Clin Gastroenterol. 2009;43(6):554–558.CrossRefPubMed
32.
Zurück zum Zitat Larsen M, Hills N, Terdiman J. The impact of the quality of colon preparation on follow-up colonoscopy recommendations. Am J Gastroenterol. 2011;106(12):2058–2062.CrossRefPubMed Larsen M, Hills N, Terdiman J. The impact of the quality of colon preparation on follow-up colonoscopy recommendations. Am J Gastroenterol. 2011;106(12):2058–2062.CrossRefPubMed
33.
Zurück zum Zitat Murff HJ, Peterson NB, Greevy RA, Shrubsole MJ, Zheng W. Early initiation of colorectal cancer screening in individuals with affected first-degree relatives. J Gen Intern Med. 2007;22(1):121–126.CrossRefPubMedCentralPubMed Murff HJ, Peterson NB, Greevy RA, Shrubsole MJ, Zheng W. Early initiation of colorectal cancer screening in individuals with affected first-degree relatives. J Gen Intern Med. 2007;22(1):121–126.CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Murray MF, Giovanni MA, Klinger E, et al. Comparing Electronic Health Record Portals to Obtain Patient-Entered Family Health History in Primary Care. J Gen Intern Med. 2013. Murray MF, Giovanni MA, Klinger E, et al. Comparing Electronic Health Record Portals to Obtain Patient-Entered Family Health History in Primary Care. J Gen Intern Med. 2013.
35.
Zurück zum Zitat Schenck AP, Klabunde CN, Warren JL, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2118–2127.CrossRefPubMed Schenck AP, Klabunde CN, Warren JL, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2118–2127.CrossRefPubMed
36.
Zurück zum Zitat Joseph DA, King JB, Miller JW, Richardson LC. Centers for Disease Control and Prevention. Prevalence of colorectal cancer screening among adults–Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):51–56.PubMed Joseph DA, King JB, Miller JW, Richardson LC. Centers for Disease Control and Prevention. Prevalence of colorectal cancer screening among adults–Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):51–56.PubMed
37.
Zurück zum Zitat Mitka M. Colorectal cancer screening rates still fall far short of recommended levels. JAMA. 2008;299(6):622.CrossRefPubMed Mitka M. Colorectal cancer screening rates still fall far short of recommended levels. JAMA. 2008;299(6):622.CrossRefPubMed
38.
Zurück zum Zitat Slomski A. Expert panel offers advice to improve screening rates for colorectal cancer. JAMA. 2010;303(14):1356–1357.CrossRefPubMed Slomski A. Expert panel offers advice to improve screening rates for colorectal cancer. JAMA. 2010;303(14):1356–1357.CrossRefPubMed
40.
Zurück zum Zitat Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127(6):1670–1677.CrossRefPubMed Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127(6):1670–1677.CrossRefPubMed
Metadaten
Titel
Overuse of Colonoscopy for Colorectal Cancer Screening and Surveillance
verfasst von
Gina R. Kruse, MD, MS, MPH
Sami M. Khan, BA
Alan M. Zaslavsky, PhD
John Z. Ayanian, MD, MPP
Thomas D. Sequist, MD, MPH
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2015
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-3015-6

Weitere Artikel der Ausgabe 3/2015

Journal of General Internal Medicine 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.